NCT06652347 Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.
| NCT ID | NCT06652347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fox Chase Cancer Center |
| Condition | Care Delivery |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-02-21 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-02-21 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This Interventional clinical study aims to explore how receiving information about their health and physical abilities affects the treatment decisions of older adults. The study will look at whether sharing detailed assessments of their health and functional status helps older adults better understand their condition and make informed decisions about their care. The main question it aims to answer is if providing this information changes the treatment priorities of older adults, helping them focus on what matters most to them in their medical care.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 65 At the time of study screening either: * Started a new qualifying index regimen within the last 30 days (inclusive) * Are being considered for a new qualifying index regimen Exclusion Criteria: * Patients will be excluded if they * Do not have the capacity to consent to study procedures * Are unable to complete English language questionnaires * Are already using an activity tracker on a daily basis (and therefore may be aware of their current level of activity) * Are enrolled in another study in which physical activity is a substantial part or all of the therapeutic intervention or where physical activity is specifically being evaluated and shared with patients. Patients on studies not evaluating or sharing physical activity are eligible for the present study if they meet the other inclusion/exclusion criteria and participation in the present study is not excluded by other studies in which they are enrolled.
Contact & Investigator
Zachary Frosch, MD, MSHP
PRINCIPAL INVESTIGATOR
Fox Chase Cancer Center
Frequently Asked Questions
Who can join the NCT06652347 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Care Delivery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06652347 currently recruiting?
Yes, NCT06652347 is actively recruiting participants. Contact the research team at Zachary.Frosch@fccc.edu for enrollment information.
Where is the NCT06652347 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06652347 clinical trial?
NCT06652347 is sponsored by Fox Chase Cancer Center. The principal investigator is Zachary Frosch, MD, MSHP at Fox Chase Cancer Center. The trial plans to enroll 100 participants.